Stockholm - November 30th 2016 Patient Specific Dosimetry optimizes therapeutic radionuclide treatment to the maximum safe dose to the patient’s healthy tissue. Each patient responds differently...

Eisai Inc. announced today the presentation of new data from studies of eribulin, marketed under the brand name Halaven®, at the 2016 San Antonio Breast Cancer Symposium (SABCS). Two ongoing...

OUTFRONT Media Inc. (NYSE: OUT), announced today that Jeremy Male, Chairman & Chief Executive Officer, is scheduled to present at the UBS 44th Annual Global Media and Communications Conference in...

Eseye and Amazon Web Services today announced the launch of a breakthrough in IoT Security, AnyNet Secure™. Eseye, a leading global cellular machine-to-machine (M2M) connectivity provider for...

Amgen (NASDAQ:AMGN) today announced new data will be presented at the 58th Annual Meeting and Exposition of the American Society of Hematology (ASH), Dec. 3 – 6, 2016, in San Diego. "The...